Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 074713
Company: BEDFORD
Company: BEDFORD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CISPLATIN | CISPLATIN | 10MG/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
CISPLATIN | CISPLATIN | 50MG/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/14/2000 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/74713ltr.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
05/11/2001 | SUPPL-1 | Manufacturing (CMC)-Facility |
Label is not available on this site. |